Pfs230: from malaria transmission-blocking vaccine candidate toward function.
Williamson
Kim C
KC
Department of Biology, Loyola University Chicago, Chicago, Illinois 60626, USA. kwilli4@luc.edu
D000818:Animals; D000913:Antibodies, Protozoan / Q000494:pharmacology; D000953:Antigens, Protozoan / Q000235:genetics / Q000276:immunology*; D009033:Culicidae / Q000469:parasitology; D005260:Female; D017125:Genes, Protozoan; D006801:Humans; D017780:Malaria Vaccines / Q000276:immunology / Q000494:pharmacology*; D016778:Malaria, Falciparum / Q000276:immunology / Q000517:prevention & control / Q000635:transmission; D008297:Male; D010963:Plasmodium falciparum / Q000235:genetics / Q000254:growth & development / Q000276:immunology; D015800:Protozoan Proteins / Q000235:genetics / Q000276:immunology*; D011994:Recombinant Proteins / Q000235:genetics / Q000276:immunology
D000913:Antibodies, Protozoan; D000953:Antigens, Protozoan; D017780:Malaria Vaccines; C430263:Pfs230 antigen, Plasmodium falciparum; D015800:Protozoan Proteins; D011994:Recombinant Proteins